PURPOSE: To evaluate ovarian cancer staging and tumor resectability with computed tomography (CT) or magnetic resonance (MR) imaging. MATERIALS AND METHODS: Eighty-two women underwent CT (n = 43) or MR imaging (n = 50); eleven of these 82 underwent both. Imaging was performed within 4 weeks of surgical staging. Radiologic, surgical, and histopathologic findings were compared. RESULTS: Overall staging accuracy was similar for CT and MR imaging (77% [33 of 43] vs 78% [39 of 50]). Evaluation of pelvic cancer extent was better with MR imaging than with CT. There was no difference in detection of abdominal disease. Most mesenteric and small-bowel implants were not detected with either CT or MR imaging. For CT, the positive predictive value for cancer nonresectability was 100% (three of three patients); the negative predictive value was 92% (37 of 40 patients). The positive and negative predictive values for MR imaging were 91% (10 of 11 patients) and 97% (38 of 39 patients). CONCLUSION: While the staging accuracy of both CT and MR imaging is only moderate, prediction of tumor resectability is excellent.
PURPOSE: To evaluate ovarian cancer staging and tumor resectability with computed tomography (CT) or magnetic resonance (MR) imaging. MATERIALS AND METHODS: Eighty-two women underwent CT (n = 43) or MR imaging (n = 50); eleven of these 82 underwent both. Imaging was performed within 4 weeks of surgical staging. Radiologic, surgical, and histopathologic findings were compared. RESULTS: Overall staging accuracy was similar for CT and MR imaging (77% [33 of 43] vs 78% [39 of 50]). Evaluation of pelvic cancer extent was better with MR imaging than with CT. There was no difference in detection of abdominal disease. Most mesenteric and small-bowel implants were not detected with either CT or MR imaging. For CT, the positive predictive value for cancer nonresectability was 100% (three of three patients); the negative predictive value was 92% (37 of 40 patients). The positive and negative predictive values for MR imaging were 91% (10 of 11 patients) and 97% (38 of 39 patients). CONCLUSION: While the staging accuracy of both CT and MR imaging is only moderate, prediction of tumor resectability is excellent.
Authors: M A L van Lankveld; P H M Peeters; M A van Eijkeren; V C M Koot; P O Witteveen; W P Th M Mali Journal: Med Oncol Date: 2004 Impact factor: 3.064
Authors: A C Tsili; C Tsampoulas; M Argyropoulou; I Navrozoglou; Y Alamanos; E Paraskevaidis; S C Efremidis Journal: Eur Radiol Date: 2008-01-10 Impact factor: 5.315
Authors: Ashish P Wasnik; Christine O Menias; Joel F Platt; Usha R Lalchandani; Deepak G Bedi; Khaled M Elsayes Journal: World J Radiol Date: 2013-03-28
Authors: G Ferrandina; G Sallustio; A Fagotti; G Vizzielli; A Paglia; E Cucci; A Margariti; L Aquilani; G Garganese; G Scambia Journal: Br J Cancer Date: 2009-09-08 Impact factor: 7.640